Li X - Search Results

1

Phase I clinical trial of HC-1119: A deuterated form of enzalutamide.

Li X, Cheng K, Li X, Zhou Y, Liu J, Zeng H, Chen Y, Liu X, Zhang Y, Wang Y, Bi F, Zheng L. Li X, et al. Int J Cancer. 2021 Oct 1;149(7):1473-1482. doi: 10.1002/ijc.33706. Epub 2021 Jul 7. Int J Cancer. 2021. PMID: 34109624 Clinical Trial.

2

Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?

Zhang Y, Li XY, Tang Y, Xu Y, Guo WH, Li YC, Liu XK, Huang CY, Wang YS, Wei YQ. Zhang Y, et al. Lung Cancer. 2013 Aug;81(2):302-5. doi: 10.1016/j.lungcan.2013.04.005. Epub 2013 May 15. Lung Cancer. 2013. PMID: 23683536

3

NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients.

Li X, Guo F, Liu Y, Chen HJ, Wen F, Zou B, Li D, Qin Q, Liu X, Shen Y, Wang Y. Li X, et al. Among authors: li d. Oncol Lett. 2015 Sep;10(3):1533-1540. doi: 10.3892/ol.2015.3471. Epub 2015 Jul 8. Oncol Lett. 2015. PMID: 26622704 Free PMC article.

4

Zoledronic acid increases the antitumor effect of gefitinib treatment for non-small cell lung cancer with EGFR mutations.

Feng C, Liu X, Li X, Guo F, Huang C, Qin Q, Wang Y. Feng C, et al. Among authors: li x. Oncol Rep. 2016 Jun;35(6):3460-70. doi: 10.3892/or.2016.4741. Epub 2016 Apr 13. Oncol Rep. 2016. PMID: 27109760

5

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC.

Jiang L, Guo F, Liu X, Li X, Qin Q, Shu P, Li Y, Wang Y. Jiang L, et al. Among authors: li y, li x. Sci Rep. 2019 Mar 6;9(1):3705. doi: 10.1038/s41598-018-38068-3. Sci Rep. 2019. PMID: 30842489 Free PMC article.

6

A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours.

Li X, Qiu M, Wang S, Zhu H, Feng B, Zheng L. Li X, et al. Cancer Chemother Pharmacol. 2020 Mar;85(3):593-604. doi: 10.1007/s00280-020-04031-1. Epub 2020 Feb 1. Cancer Chemother Pharmacol. 2020. PMID: 32008115 Clinical Trial.

7

Low-Dose Radiation Therapy Promotes Radiation Pneumonitis by Activating NLRP3 Inflammasome.

Li X, Gong Y, Li D, Xiang L, Ou Y, Jiang L, Shu P, Liu X, Guo F, Qin D, Mo Z, Qin Q, Wang X, Wang Y. Li X, et al. Among authors: li d. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):804-814. doi: 10.1016/j.ijrobp.2020.02.643. Epub 2020 Apr 22. Int J Radiat Oncol Biol Phys. 2020. PMID: 32334032

8

Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models.

Qin D, Li D, Zhang B, Chen Y, Liao X, Li X, Alexander PB, Wang Y, Li QJ. Qin D, et al. Among authors: li d, li x, li qj. Oncoimmunology. 2020 Aug 15;9(1):1806009. doi: 10.1080/2162402X.2020.1806009. Oncoimmunology. 2020. PMID: 32923168 Free PMC article.

9

Safety, Efficacy, and Pharmacokinetics of Metatinib Tromethamine Tablet in Patients with Advanced Refractory Solid Tumors: A Phase I Clinical Trial.

Cheng K, Li XY, Zhou YW, Liao ZY, Qiu M, Bi F, Zheng L. Cheng K, et al. Oncologist. 2021 Aug;26(8):649-e1313. doi: 10.1002/onco.13760. Epub 2021 Apr 24. Oncologist. 2021. PMID: 33749934 Free PMC article. Clinical Trial.

10

Clinical study of drug-drug interaction between omeprazole and pyrotinib after meal.

Li X, Wang Y, Zhu X, Zheng L. Li X, et al. Br J Clin Pharmacol. 2022 May;88(5):2349-2358. doi: 10.1111/bcp.15169. Epub 2021 Dec 28. Br J Clin Pharmacol. 2022. PMID: 34873745 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,202 results

Search Page

Filters